[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gastroparesis Drugs Market Size, Status and Forecast 2022

October 2017 | 99 pages | ID: GDE93E3D5A5WEN
QYResearch

US$ 3,300.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies the global Gastroparesis Drugs market, analyzes and researches the Gastroparesis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
  • GlaxoSmithKline
  • Johnson & Johnson
  • Cadila Pharmaceuticals
  • Valeant
  • Evoke Pharma
  • Teva Pharmaceutical Industries
  • Theravance Biopharma
  • ...
Market segment by Regions/Countries, this report covers
  • United States
  • EU
  • Japan
  • China
  • India
  • Southeast Asia
Market segment by Type, Gastroparesis Drugs can be split into
  • Prokinetic Agents
  • Antiemetic Agents
  • Botulinum Toxin Injection
  • Other
Market segment by Application, Gastroparesis Drugs can be split into
  • Diabetic Gastroparesis
  • Idiopathic Gastroparesis
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Gastroparesis Drugs Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF GASTROPARESIS DRUGS

1.1 Gastroparesis Drugs Market Overview
  1.1.1 Gastroparesis Drugs Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Gastroparesis Drugs Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Gastroparesis Drugs Market by Type
  1.3.1 Prokinetic Agents
  1.3.2 Antiemetic Agents
  1.3.3 Botulinum Toxin Injection
  1.3.4 Other
1.4 Gastroparesis Drugs Market by End Users/Application
  1.4.1 Diabetic Gastroparesis
  1.4.2 Idiopathic Gastroparesis

2 GLOBAL GASTROPARESIS DRUGS COMPETITION ANALYSIS BY PLAYERS

2.1 Gastroparesis Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 GlaxoSmithKline
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 Johnson & Johnson
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Cadila Pharmaceuticals
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Valeant
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Evoke Pharma
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Teva Pharmaceutical Industries
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Theravance Biopharma
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Gastroparesis Drugs Revenue (Value) (2012-2017)
  3.7.5 Recent Developments

4 GLOBAL GASTROPARESIS DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Gastroparesis Drugs Market Size by Type (2012-2017)
4.2 Global Gastroparesis Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Gastroparesis Drugs in Future
4.4 Top Consumer/End Users of Gastroparesis Drugs

5 UNITED STATES GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Gastroparesis Drugs Market Size (2012-2017)
5.2 United States Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Gastroparesis Drugs Market Size (2012-2017)
6.2 EU Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

7 JAPAN GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Gastroparesis Drugs Market Size (2012-2017)
7.2 Japan Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

8 CHINA GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

8.1 China Gastroparesis Drugs Market Size (2012-2017)
8.2 China Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

9 INDIA GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

9.1 India Gastroparesis Drugs Market Size (2012-2017)
9.2 India Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA GASTROPARESIS DRUGS DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Gastroparesis Drugs Market Size (2012-2017)
10.2 Southeast Asia Gastroparesis Drugs Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Gastroparesis Drugs Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
  11.1.2 EU Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
  11.1.4 China Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
  11.1.5 India Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Gastroparesis Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Gastroparesis Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Gastroparesis Drugs Market Size by Application (2017-2022)

12 GASTROPARESIS DRUGS MARKET DYNAMICS

12.1 Gastroparesis Drugs Market Opportunities
12.2 Gastroparesis Drugs Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Gastroparesis Drugs Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Gastroparesis Drugs Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Gastroparesis Drugs Product Scope
Figure Global Gastroparesis Drugs Market Size (Million USD) (2012-2017)
Table Global Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Gastroparesis Drugs Market Share by Regions in 2016
Figure United States Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Gastroparesis Drugs Market Share by Type in 2016
Figure Prokinetic Agents Market Size (Million USD) and Growth Rate (2012-2017)
Figure Antiemetic Agents Market Size (Million USD) and Growth Rate (2012-2017)
Figure Botulinum Toxin Injection Market Size (Million USD) and Growth Rate (2012-2017)
Figure Other Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Gastroparesis Drugs Market Share by Application in 2016
Table Key Downstream Customer in Diabetic Gastroparesis
Figure Gastroparesis Drugs Market Size (Million USD) and Growth Rate in Diabetic Gastroparesis (2012-2017)
Table Key Downstream Customer in Idiopathic Gastroparesis
Figure Gastroparesis Drugs Market Size (Million USD) and Growth Rate in Idiopathic Gastroparesis (2012-2017)
Figure Gastroparesis Drugs Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
Table Gastroparesis Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Gastroparesis Drugs Market Size Share by Players in 2016
Figure Gastroparesis Drugs Market Size Share by Players in 2017
Table GlaxoSmithKline Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Gastroparesis Drugs Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Gastroparesis Drugs Business Revenue Market Share in 2016
Table Cadila Pharmaceuticals Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Cadila Pharmaceuticals (2012-2017)
Figure Cadila Pharmaceuticals Gastroparesis Drugs Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Gastroparesis Drugs Business Revenue Market Share in 2016
Table Evoke Pharma Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Evoke Pharma (2012-2017)
Figure Evoke Pharma Gastroparesis Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries Gastroparesis Drugs Business Revenue Market Share in 2016
Table Theravance Biopharma Basic Information List
Table Gastroparesis Drugs Business Revenue (Million USD) of Theravance Biopharma (2012-2017)
Figure Theravance Biopharma Gastroparesis Drugs Business Revenue Market Share in 2016
Table Global Gastroparesis Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Gastroparesis Drugs Market Size Share by Type in 2012
Figure Global Gastroparesis Drugs Market Size Share by Type in 2013
Figure Global Gastroparesis Drugs Market Size Share by Type in 2014
Figure Global Gastroparesis Drugs Market Size Share by Type in 2015
Figure Global Gastroparesis Drugs Market Size Share by Type in 2016
Figure Global Gastroparesis Drugs Market Size Share by Type in 2017
Table Global Gastroparesis Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2012
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2013
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2014
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2015
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2016
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Gastroparesis Drugs
Figure United States Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Gastroparesis Drugs Market Size Share by Players in 2016
Figure United States Gastroparesis Drugs Market Size Share by Players in 2017
Figure EU Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Gastroparesis Drugs Market Size Share by Players in 2016
Figure EU Gastroparesis Drugs Market Size Share by Players in 2017
Figure Japan Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Gastroparesis Drugs Market Size Share by Players in 2016
Figure Japan Gastroparesis Drugs Market Size Share by Players in 2017
Figure China Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Gastroparesis Drugs Market Size Share by Players in 2016
Figure China Gastroparesis Drugs Market Size Share by Players in 2017
Figure India Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Gastroparesis Drugs Market Size Share by Players in 2016
Figure India Gastroparesis Drugs Market Size Share by Players in 2017
Figure Southeast Asia Gastroparesis Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Gastroparesis Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Gastroparesis Drugs Market Size Share by Players in 2016
Figure Southeast Asia Gastroparesis Drugs Market Size Share by Players in 2017
Figure Global Gastroparesis Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Gastroparesis Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Gastroparesis Drugs Market Size Share by Regions in 2017
Figure Global Gastroparesis Drugs Market Size Share by Regions in 2022
Figure United States Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Gastroparesis Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Gastroparesis Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Gastroparesis Drugs Market Size Share by Type in 2017
Figure Global Gastroparesis Drugs Market Size Share by Type in 2022
Table Global Gastroparesis Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2017
Figure Global Gastroparesis Drugs Market Size (Million USD) by Application in 2022


More Publications